https://www.reuters.com/business/healthcare-pharmaceuticals/japan-grants-priority-review-status-alzheimers-treatment-eisai-biogen-2023-01-29/
0
0
1/30/23 at 12:44am
Organization
Reuters
Authors
Japanese drugmaker Eisai Co Ltd <a href="https://www.reuters.com/companies/4523.T" target="_blank">(4523.T)</a> and U.S. biotech firm Biogen Inc <a href="https://www.reuters.com/companies/BIIB.O" target="_blank">(BIIB.O)</a> said in a joint statement that the…
Create an account
or login to join the discussion